XT1 Stock Chart & Stats
€33.80
€0.00(0.00%)
At close: 4:00 PM EST
€33.80
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€31.20 - €59.00
Previous CloseN/A
Volume0.00
Average Volume (3M)25.00
Market Cap
€1.54B
Enterprise Value€1.39K
Total Cash (Recent Filing)€90.85M
Total Debt (Recent Filing)€94.96M
Price to Earnings (P/E)25.4
Beta0.48
Next Earnings
Jul 28, 2026EPS Estimate
0.53Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.37
Shares Outstanding28,592,910
10 Day Avg. Volume25
30 Day Avg. Volume25
Financial Highlights & Ratios
PEG Ratio1.24
Price to Book (P/B)2.29
Price to Sales (P/S)2.33
P/FCF Ratio14.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.05
Revenue Forecast (FY)€482.18M
Bulls Say, Bears Say
Bulls Say
Diversified End MarketsCTS’s strategic shift toward diversified markets (now ~58% of revenue) reduces dependence on cyclical automotive volumes, smoothing revenue cycles and enabling growth in higher‑margin medical, industrial and defense programs. This structural mix aids multi‑year resilience and win‑rates for design‑in positions.
Margin Expansion & ProfitabilitySustained gross margin near 39% and double‑digit operating/net margins reflect durable cost control, favorable product mix and operational improvements. Higher margins provide buffer against demand swings and support reinvestment, dividends and targeted M&A over the medium term.
Strong Cash Generation & Low LeverageConsistent positive free cash flow and modest leverage (~0.22 D/E) support financial flexibility for capex, share repurchases and targeted investments. Reliable cash conversion underpins capital returns and enables funding of capacity expansion in medical and industrial segments without stressing the balance sheet.
Bears Say
Choppy Revenue GrowthTop‑line growth has been uneven, with declines in 2023–24 and only modest TTM gains. Persistent variability in revenue slows operating leverage, makes forecasting harder, and increases reliance on margin expansion or M&A to drive EPS, exposing results to timing of large program ramps.
Input‑Cost & Tariff PressureSustained inflation in key inputs (precious metals, resins, logistics) and potential tariff changes can compress margins if passthrough to customers is limited. Over several quarters, these structural cost trends could erode the margin cushion and require pricing, sourcing or design changes to sustain profitability.
A&D Booking Lumps & TimingAerospace & defense revenues are lumpy and dependent on irregular government funding; weak A&D bookings and sub‑1 book‑to‑bill increase near‑term revenue volatility. Reliance on recovery in H2 creates execution risk and uneven cash flow if awards or funding timelines shift.
CTS News
XT1 FAQ
What was CTS Corporation’s price range in the past 12 months?
CTS Corporation lowest stock price was €31.20 and its highest was €59.00 in the past 12 months.
What is CTS Corporation’s market cap?
CTS Corporation’s market cap is €1.54B.
When is CTS Corporation’s upcoming earnings report date?
CTS Corporation’s upcoming earnings report date is Jul 28, 2026 which is in 5 days.
How were CTS Corporation’s earnings last quarter?
CTS Corporation released its earnings results on Apr 29, 2026. The company reported €0.543 earnings per share for the quarter, beating the consensus estimate of €0.455 by €0.088.
Is CTS Corporation overvalued?
According to Wall Street analysts CTS Corporation’s price is currently Overvalued.
Does CTS Corporation pay dividends?
CTS Corporation does not currently pay dividends.
What is CTS Corporation’s EPS estimate?
CTS Corporation’s EPS estimate is 0.53.
How many shares outstanding does CTS Corporation have?
CTS Corporation has 28,592,910 shares outstanding.
What happened to CTS Corporation’s price movement after its last earnings report?
CTS Corporation reported an EPS of €0.543 in its last earnings report, beating expectations of €0.455. Following the earnings report the stock price went down -3.361%.
Which hedge fund is a major shareholder of CTS Corporation?
Currently, no hedge funds are holding shares in DE:XT1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CTS Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
48.19%
12-Months-Change
Fundamentals
Return on Equity
0.28%
Trailing 12-Months
Asset Growth
1.52%
Trailing 12-Months
Company Description
CTS Corporation
CTS Corporation is a global enterprise specializing in the production and distribution of vital electronic components, such as sensors, actuators, and connectivity solutions, with operations spanning North America, Europe, and Asia. Its extensive product line includes specialized sensors and actuators developed for both passenger and commercial vehicles. Additionally, CTS provides advanced connectivity components crucial for telecommunications infrastructure, information technology networks, and other high-speed applications. The company also offers a broad array of switches, temperature sensors, and potentiometers, serving various industries. Furthermore, it fabricates piezoelectric materials and substrates primarily utilized in demanding sectors like medical, industrial, aerospace and defense, and information technology. CTS effectively markets and sells its offerings through a multi-faceted approach, leveraging its internal sales engineers, independent manufacturers' representatives, and an established network of distributors. The company, which traces its origins back to 1896, currently maintains its corporate headquarters in Lisle, Illinois.